文献速递前列腺癌

前列腺癌长期生存者中稳健的健康效用评估:来自前列腺癌战略泌尿学研究尝试登记处的结

Robust Health Utility Assessment Among Long-term Survivors of Prostate Cancer: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Registry.
PubMed 文献 · Eur Urol · 2019-07-23

该研究是在前瞻性队列CaPSURE中嵌套的横断面研究,采用标准博弈法量化前列腺癌长期生存者的健康效用。1740例患者平均年龄73.1±8.2岁,诊断后中位9年,前列腺癌健康与总体健康平均效用分别为0.934±0.120和0.960±0.100,偏倚校正后仍较高。作者认为长期生存者效用远高于既往报告,体现较强适应力。

要点

  • 前列腺癌长期生存者标准博弈法效用值较高,前列腺癌健康平均0.934,总体健康平均0.960。
  • 偏倚校正后效用仍高,概率加权法为0.866和0.897,混合模型法为0.845和0.884。
  • 即使功能未完全恢复,多数患者随时间适应健康状况,不愿为更好生活质量承担风险。

核心结论

  • 前列腺癌长期生存者基于标准博弈法的效用值远高于既往报告,提示患者随时间适应健康状况,即使功能未完全恢复也不愿为更好生活质量承担风险。

研究设计与样本

  • 研究为嵌套于前瞻性队列CaPSURE的横断面研究,3155名活跃参与者中1884名(59.7%)返回问卷,排除不完整或不合格数据后1740例(占应答者92.3%)纳入最终分析。
  • 患者平均年龄73.1±8.2岁,诊断后中位时间9年(四分位距6-11年),接受多种前列腺癌主要治疗。

主要发现

  • 前列腺癌健康与总体健康的平均效用分别为0.934±0.120和0.960±0.100。
  • 经概率加权函数偏倚校正后,前列腺癌健康与总体健康效用分别为0.866±0.154和0.897±0.142。
  • 经混合模型校正后,前列腺癌健康与总体健康效用分别为0.845±0.186和0.884±0.176。
  • 特定功能结局的效用值同样较高,即使经过偏倚校正。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 生存者偏倚和前列腺癌自然病史导致疾病状态比例偏斜是潜在局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Valid health utility values are essential for comparative effectiveness analyses. However, subjective utilities in long-term survivors of prostate cancer (PCa) with various oncological and functional outcomes have not been well described. OBJECTIVE: To quantify utilities in long-term survivors of PCa using the standard gamble method, generally regarded as the approach best grounded in economic theory. DESIGN, SETTING, AND PARTICIPANTS: We performed a cross-sectional study nested within a prospective cohort-Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). Overall, 1884 (59.7%) of 3155 active participants across all disease states returned the questionnaire. INTERVENTION: Various primary treatments for PCa. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Utility values for PCa health, sexual function, urinary function, bowel function, and overall health were measured, based on patients' conditions at the time of the survey. Bias correction methods were employed. RESULTS AND LIMITATIONS: After exclusion of incomplete or disqualified data, 1740 (92.3% of responding) patients were included in the final analysis. The mean age was 73.1 ± 8.2 yr at a median of 9 yr (interquartile range: 6-11) since diagnosis. Mean utilities for PCa health and overall health were 0.934 ± 0.120 and 0.960 ± 0.100, respectively. After bias correction by probability weighting function, utilities were 0.866 ± 0.154 and 0.897 ± 0.142, and by mixed model correction, 0.845 ± 0.186 and 0.884 ± 0.176, respectively. Measured utilities were similarly high for specific functional outcomes, even with bias corrections. Survivorship bias and skewed proportion of disease status due to natural history of PCa were potential limitations. CONCLUSIONS: Standard gamble-based utilities in long-term survivors of PCa were much higher than those determined previously. The results indicate substantial human resilience: most PCa patients adapt to their health status over time even if they experience incomplete functional recovery and would not take risk in pursuit of better quality of life. PATIENT SUMMARY: We elicited health utilities (measures of quality of life) among long-term survivors of prostate cancer using the most robust method. These were much higher than previously reported values that were based on theoretical scenarios or indirect methods. Long-term survivors of prostate cancer may adapt well to their health conditions over time even if they experience disease-specific or functional problems.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Jeong CW, Cowan JE, Broering JM, et al. Robust Health Utility Assessment Among Long-term Survivors of Prostate Cancer: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Registry. Eur Urol. 2019. PMID: 31345635. doi:10.1016/j.eururo.2019.07.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。